Navigation Links
Ranbaxy Laboratories All Set To Export Bird Flu Vaccines

In view, of the ever-increasing threat about bird flu worldwide, there has been a healthy competition among several pharmaceutical companies to manufacture the drug.// Ranbaxy Laboratories has become the first Indian company to start shipments of generic version of bird flu drug, Tamiflu. The drug is believed to get shipped to a country where the patent held by the Swedish major Roche would be invalid.

We have sent small quantities of the avian flu drug to a government, where Roche has no patent on the drug', said Dr Brian Tempest, CEO of Ranbaxy and managing director of Ranbaxy. The company has already developed the chemistry to produce the drug and scaled it up to a certain level for sending supplies to another government.

The company is expecting a feedback from Roche regarding sub-licensing for supplying drug to other countries. The patent for the avian flu drug (Tamiflu) is being held by the Swedish manufacturer in most of the countries. Four main pharmaceutical companies including Teva Pharmaceuticals, Mylan Laboratories, Barr Laboratories and Ranbaxy have been in talks with the drug company to manufacture a generic version of the patented drug.

The worldwide demand for the flu drug and concerns regarding the outbreak of an epidemic has prompted for relaxation for rules regarding the drug manufacture. Owing to the above situation, Roche has been subjected to extreme pressure from several Governments across the world.


'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading performance strength training ... of the Houston Rockets the NBSCA Strength & Conditioning Coach of the Year. ... members who vote to select the coach who embodies the highest level of excellence ...
(Date:6/27/2017)... ... 27, 2017 , ... A+ Orthodontics is now offering special ... on treating alignment and occlusion irregularities. Treatment often includes the use of braces ... Hollywood dentist , Dr. Garemani, along with Dr. Reza and the rest of ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... Children’s National ... Children’s Hospitals rankings, with its Neonatology program ranking #1 out of more than ... also named to the coveted Honor Roll, a distinction given to the top performing ...
(Date:6/26/2017)... ... ... Antoine Dental Center is now offering various types of dental implants to restore ... support for prosthetic teeth, such as crowns, bridges, or dentures. An implant is placed directly ... new root for the tooth. , Several types of dental implants are available, including: ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: